Drug intelligence / Profile preview

Vitality Repair Peptide

Development stage: Preclinical
Lead developer: JNU Biopharmaceutical Group
Modality: Peptides
Administration: Topical

Overview

Vitality Repair Peptide (活力修复肽) is a peptide-based candidate developed by JNU Biopharmaceutical Group (Jinan University Biopharmaceutical Group). It is positioned within the company's pipeline for applications in regenerative medicine and medical aesthetics, specifically focusing on skin repair and tissue revitalization. While the specific amino acid sequence and molecular targets are not publicly disclosed, the product is designed to facilitate cellular recovery and promote healing, likely following dermatological procedures or skin injury. As a product of JNU Biopharmaceutical Group, which specializes in recombinant protein and peptide technology, it represents a targeted approach to enhancing the skin's natural regenerative processes.

Other names: 活力修复肽

Beyond the preview

Go deeper on Vitality Repair Peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitality Repair Peptide.

Explore the full profile